Myasthenia gravis (MG) is a chronic autoimmune neuromuscular disorder that primarily affects the voluntary movement-controlling muscles. The condition is characterized by fatigue and muscle weakness that worsen with activity and improve with relaxation. The term "myasthenia gravis" derives from the Greek for "grave muscle weakness." Here is how MG operates: • Myasthenia gravis is an autoimmune disorder in which the immune system erroneously targets and attacks the acetylcholine receptor (AChR) or other proteins involved in nerve-muscle communication at the neuromuscular junction. Neuronal signals from motor neurons stimulate muscle contractions at the neuromuscular junction. • Impaired Nerve-Muscle Communication: In a healthy neuromuscular junction, nerve signals release the neurotransmitter acetylcholine (ACh), which binds to ACh receptors on the membranes of muscle cells, causing muscle contractions. In myasthenia gravis, the autoimmune attack damages or reduces the number of ACh receptors on the membrane of muscle cells, thereby impeding the transmission of nerve signals to the muscles. • Muscle Weakness: Due to impaired nerve-muscle communication, the muscles receive fewer signals from the nerves, resulting in muscle weakness, particularly during repetitive or prolonged activities. Eyelid lowering (ptosis), double vision (diplopia), difficulty swallowing (dysphagia), and generalized muscle weakness are typical MG symptoms. • MG is characterized by fluctuating symptoms, with muscle weakness getting worse with activity and getting better with relaxation. This variation in symptoms can make diagnosing MG difficult. • There is no cure for myasthenia gravis, but there are several treatment options available to manage the condition and alleviate symptoms. These treatments may include cholinesterase inhibitors, immunosuppressive medicines, and plasma exchange or intravenous immunoglobulin (IVIG) treatments. In severe cases, surgical interventions such as thymectomy (thymus gland excision) may be advised. The severity and progression of MG can differ from individual to individual. Many people with myasthenia gravis can lead relatively normal lives and obtain good symptom control with the proper treatment. Individuals with MG must work closely with healthcare professionals, such as neurologists and immunologists, to develop a personalized treatment plan that addresses their specific requirements.